Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy

被引:15
|
作者
Friedman, AN
Hunsicker, LG
Selhub, J
Bostom, AG
机构
[1] Tufts Univ, Human Nutr Res Ctr Aging, Jean Mayer USDA, Boston, MA 02111 USA
[2] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA USA
[3] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[4] Rhode Isl Hosp, Div Renal Dis, Providence, RI USA
关键词
D O I
10.2337/diacare.25.11.2037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Patients with diabetes who manifest proteinuria are at increased risk for cardiovascular events. Some studies suggest that proteinuria exerts its cardiovascular effects at feast partly through a positive association with total plasma homocysteine (tHcy). Modestly sized but better designed contrary studies find no such link through a limited range of serum creatinine and proteinuria. We tested the hypothesis that proteinuria independently predicts tHcy levels in a larger cohort of type 2 diabetic patients with nephropathy throughout a much broader range of kidney disease and proteinuria. RESEARCH DESIGN AND METHODS - Baseline data for the cross-sectional study were obtained from 717 patients enrolled in the multicenter Irbesartan Diabetic Nephropathy Trial. All subjects had type 2 diabetes, hypertension, and proteinuria and were between 29 and 78 years of age. Data included age, sex, BMI, serum creatinine and albumin, LDL and HDL cholesterol, triglyceride, proteinuria and albuminuria, plasma folate, B12, and pyridoxal 5'-phosphate (PLP) (the active form of B6), HbA(1c), and tHcy levels. Unadjusted and multivariable models were used in the analysis. RESULTS - Crude analyses revealed significant associations between tHcy and age (r = 0.074; P = 0.008), creatinine (r = 0.414; P < 0.001), PLP (r = -0.105; P = 0.021), B12 (r = -0.216; P < 0.001), folate (r = -0.241; P < 0.001), and HbA(1c) (r = -0.119; P = 0.003), with serum albumin approaching significance (r = 0.055; P = 0.072). Only serum creatinine, plasma folate, B12, serum albumin, sex, HbA(1c), and age were independent predictors of tHcy after controlling for all other variables. CONCLUSIONS - By finding no independent correlation between proteinuria (or albuminuria) and tHcy levels, this study improves the external validity of previous negative findings. Therefore, it is unlikely that the observed positive association between proteinuria and cardiovascular disease is directly related to hyperhomocysteinemia.
引用
收藏
页码:2037 / 2041
页数:5
相关论文
共 50 条
  • [1] Predictive ability of proteinuria in determining total plasma homocysteine levels in type II diabetic nephropathy
    Friedman, AN
    Hunsicker, L
    Lewis, E
    Rohde, R
    Selhub, J
    Bostom, AG
    [J]. DIABETES, 2002, 51 : A167 - A167
  • [2] Impacts of insulin resistance and nephropathy on plasma homocysteine levels in type 2 diabetic subjects
    Kanda, H
    Emoto, M
    Matsuyoshi, M
    Taniwaki, H
    Maekawa, K
    Shoji, T
    Okuno, Y
    Nishizawa, Y
    [J]. DIABETES, 1999, 48 : A228 - A228
  • [3] Plasma Total Homocysteine Levels in Diabetic Retinopathy
    Kayadibi, Huseyin
    Sertoglu, Erdim
    Uyanik, Andmetin
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [4] Total plasma homocysteine and arteriosclerotic outcomes in type 2 diabetes with nephropathy
    Friedman, AN
    Hunsicker, LG
    Selhub, J
    Bostom, AG
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11): : 3397 - 3402
  • [5] Relationship of diabetic nephropathy to plasma levels of IL-6, PAI-1, total homocysteine and LP(a) levels in Japanese Type 2 diabetics.
    Yokota, C
    Kawai, K
    Okuda, Y
    Katayama, S
    [J]. DIABETOLOGIA, 2003, 46 : A330 - A330
  • [6] Plasma levels of asymmetric dimethylarginine and total homocysteine in first degree relatives of type 2 diabetic patients
    Gueldiken, Sibel
    Karadag, Hakan
    Demir, Muzaffer
    Arikan, Ender
    Kara, Muejdat
    [J]. TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2007, 24 (01): : 17 - 22
  • [7] Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents
    Drzewoski, J
    Czupryniak, L
    Chwatko, G
    Bald, E
    [J]. DIABETES CARE, 1999, 22 (12) : 2097 - 2099
  • [8] Association of plasma total homocysteine levels with arterial wall thickness in type 2 diabetic and healthy subjects
    Emoto, M
    Kanda, H
    Kawagishi, T
    Komatsu, M
    Morioka, T
    Mori, K
    Tahara, H
    Shoji, T
    Okuno, Y
    [J]. DIABETES, 2000, 49 : A136 - A136
  • [9] Plasma and Saliva Irisin Levels of Patients with Diabetic Nephropathy and Non-Diabetic Proteinuria
    Gurel, Ali
    Atli, Hasan
    Duzenci, Deccane
    Aydin, Suleyman
    Dogukan, Ayhan
    [J]. TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2015, 24 (03): : 302 - 306
  • [10] Plasma homocysteine levels in type 1 diabetic patients
    Pavía, C
    Ferrer, I
    Valls, C
    Artuch, R
    Colomé, C
    Vilaseca, MA
    [J]. DIABETES CARE, 2001, 24 (05) : 970 - 971